cell therapy at a glance

Cell Therapy

Stem Cell Therapy at a Glance

Stem cell treatments, research and technology are no longer relegated to novels or movies. Research and development of stem cells also goes way beyond the use of embryonic stem cell based therapy, potential of cloning human beings and the moral and ethical controversies surrounding such developments. Today, stem cell research offers potential treatments for the future that may cure many disease processes, enable people with spinal cord injuries to walk again, and perhaps even see an end to cognitive impairment diseases such as  Alzheimer’s and Parkinson’s Disease.
Brief Overview of Stem Cell Therapy Research

To date, scientific research into stem cells has identified multiple types of stem cells and sources. The most commonly studied, and used, stem cell based therapy developments today involve the use of:

Embryonic stem cell therapy Adult stem cell therapy and research Umbilical cord stem cell therapy

At their most basic definition, stem cells have the ability to limitlessly divide and are capable of developing into one or several different types of the 220 cells found in the human body. Embryonic stem cell therapy has long been the center of controversy regarding their moral and ethical use, not only in the United States, but also around the world. These cells are taken from early stage embryos, many from aborted fetuses. Because of such controversy, scientists spent decades studying other ways to develop stem cells that would offer more
appeal and less controversy.

Adult stem cell therapy is commonly used today in a wide range of human stem cell therapy and treatments. This type of stem cell is taken from bone marrow. Adult stem cells can be “instructed” to form a certain type of cell – such as nerve cells, cardiac cells, skin cells, muscle cells and so forth. Because these cells are found in the skin, blood and bone marrow, they do not carry the stigma that embryonic stem cells do. Scientists are currently looking for ways to replace damaged cells that lead to a multitude of disease processes, such as
diabetes, Parkinson’s, and cancer. As such, stem cell replacement therapy is undergoing extensive research and development.

Umbilical cord stem cell therapy

is utilized through the blood of umbilical cords after they and the rest of the afterbirth of placenta has been expelled from the body after a baby is born. As a rich source of stem cells, many parents today are “banking” their children’s umbilical cord cells in case they are needed for curing disease in the future. Stem cell therapy research utilizing umbilical cord blood stem cell therapy is making huge advancements today. Because umbilical and adult stem cells may be collected from any given individual, the risks of rejection of organs or treatments developed with such sources are drastically reduced. This makes it possible to benefit from transplants and other procedures where rejection has commonly been an issue.

Placenta Stem Cell Therapy

A fairly recent development in stem cells therapy research, doctors have been studying the beneficial components of stem cells found within the placenta. A process that utilizes stem cells found in placenta afterbirth is considered ethical, as it does not involve any interaction with a fetus or newborn. The afterbirth, heretofore discarded after birth, is now being studied for its multipotent stem cells in the search for treatments of multiple illnesses and disease processes.

Who benefits from Stem Cells Therapy Treatments?

Stem cell technologies and advancements are being made on an almost daily basis. From Japan to China to the U.S. to Europe, Africa and Russia, the world’s scientists and medical experts have been studying, and using, stem cells treatments and stem cell therapy to treat a wide range of illnesses, injuries and disease processes, including but not limited to:

Neurological diseases such as:

Multiple Sclerosis

Parkinson’s

Cerebral Palsy

Epilepsy

Blood-borne Cancers such as:

Leukemia

Non-Hodgkin’s Lymphoma

Multiple Myeloma

Organ Cancers such as:

Breast Cancer

Prostate Cancer

Lung Cancer

Malignant Melanoma

Heart Disease processes such as:

Myocardial Infarction

Atherosclerosis

Congestive Heart Failure

Musculoskeletal Conditions and Injuries such as:

Spinal cord injury

Bone damage caused by injuries and disease

Joint injuries and diseases

Hormonal, Immune and Circulatory Issues

Auto-Immune diseases such as Rheumatoid arthritis, lupus and Muscular Dystrophy Chronic infections such as Tuberculosis and Hepatitis C

Cosmetic and Reconstruction Treatments

Breast reconstruction treatments

Facial implants

Rejuvenation therapies

Medical Stem Cell Tourism

Currently, no stem cells therapy options are available in the U.S., which prompts many Americans to venture to international destinations for them. The potential cost of stem cell therapies in the U.S. may be prohibitively expensive, which encourages those hoping and seeking cures for illnesses, injuries and disease processes to travel to China, Thailand, Japan, Europe, India, and Iran among others. The cost of therapies is determined according to geographic location of treatment facilities as well as the injury, illness or disease being treated. Because such treatments have not yet been approved in the U.S., medical travelers are cautioned to do their homework and study human stem cell therapy, treatments and protocols and examine the history as well as case studies in foreign destinations. To date, the U.S. has approved funding for Phase I clinical trials of some types of stem cell therapies that may provide productive and beneficial use in the near future.

How Do I Select a Stem Cell Provider? Ask questions – such as:

Can you offer proof that these stem cell therapy treatments work?
Can I speak with former patients who have undergone such therapies?
Who are (and what are the credentials) of the physician or surgeon administering stem cell therapies or treatments? How long has the organization offered such treatments? How safe is the treatment? Are there risks involved?

The Future of Stem Cells Therapy

According to the recent gathering of the World Stem Cell Summit in Madison, Wisconsin in September 2008, growing numbers of individuals seeking alternative or advanced forms of medical treatment, including stem cell therapies, travel to foreign destinations every year. According to their reports, such numbers are on the verge of ‘exploding’ as individuals seek safe and effective treatments for dehabilitative injuries, diseases and terminal illnesses at affordable prices not currently found in the U.S. Stem cell therapy research is running full
steam ahead, and will continue well into the 21st century.

Adult Stem Cells Overview

Stem cell research has been in the news for decades, most commonly because of controversial or morally objectionable research methodologies engaged by scientists and research groups around the world. However, individuals should also know there are several different types of stem cell research including but not limited to, adult stem cells, embryonic stem cell, placenta, and umbilical cord research. In coming years, scientists will inevitably discover other types of stem cell research, and understanding the differences between them and the capabilities of each is essential for the future of medical care, technology, and access to cutting edge medical treatment in coming years. Adult stem cells are known as undifferentiated cells. They are also known as multipotent cells capable of producing different blood cells. That means that they haven’t specifically developed or grown into a specific type of tissue or organ. Adult stem cells can renew themselves and grow or “morph” to become just about any type of specialized cell, tissue or organ tissue. There are many different types of adult stem cells, and many of them have the capacity to differentiate, or grow into specific types of stem cells that may help replenish damaged or injured cells in muscular tissue, cardiac tissue, brain and nerve tissue, among others. The basic function of adult stem cells in humans is to maintain and repair tissues in the organ or tissue where they are located. Adult stem cells are also commonly known as somatic stem cells, which are types of cells defined by their origin. Stem cell research has a very viable future of holding treatments and cures for debilitating and life-threatening illnesses and disease processes such as diabetes, Parkinson’s, Alzheimer’s, cancer, and repair of cardiac muscle tissues damaged by strokes, heart attacks, and coronary artery disease. Recent developments in stem cell research have proven positive results from using stem cells in a variety of treatments of blood disorders such as leukemia as well as vision care and cardiac care.

Where Are Adult Stem Cells Found?

Adult stem cells are found in many tissues and organs of the human body, including blood, blood vessels, the brain, bone marrow, fat, skeletal muscle, teeth, skin, and internal organs such as the liver, heart, and stomach. Adult stem cells are now believed to develop and grow in specific locations within body issues that are normally activated and put into use by needs of cells to increase tissue growth, or repair damage caused by injuries or disease. Small numbers of adult stem cells are found in various tissues, but once removed from the body have a reduced capacity to divide and multiply. Because of this, generating large
quantities of adult stem cells for research and development into therapies has long provided a hurdle to researchers. Ongoing research and development into creating cell cultures from adult stem cells in order to manipulate and encourage them to grow and multiply are ongoing.

What Are Adult Stem Cells Used for?

Adult stem cells are commonly used today as bone marrow transplants, blood trans plants and transfusions in the treatment of such diseases such as leukemia, other types of cancers and blood disorders. Adult stem cells are fairly easy to obtain and offer nearly limitless potential for supply. Stem cells cultivated from patients themselves can be utilized for their own treatments and therapies. Adult stem cell research and therapy development has already displayed promising results in treating blood diseases and some cancers. Adult stem cell research and
treatments are not considered unethical or morally wrong and ongoing discoveries makes it one of the most popular stem cell research today.
The potential use for adult stem cells in fields of treatment and research for brain diseases such as the aforementioned Parkinson’s and Alzheimer’s, as well as neuromuscular diseases such as osteoarthritis, rheumatoid arthritis, and multiple sclerosis offer hope for the future of medicine. Adult stem cells culled from bone marrow has long been used in the treatment of leukemia and is currently being developed for treatment of cancers and blood diseases. Stem cell research has been ongoing for decades, but only recently, thanks to modern high-tech equipment and technology, researchers are able to utilize a multitude of stem cells to research growth and development as well as potential effectiveness of stem cells against common diseases today. Stem cell development in a near future is likely to offer support and rejuvenation for injury to tissues and organs as well as treat spinal cord injuries and reversing heart disease, among many other beneficial uses of this invisible yet very powerful source of health and healing in the human body.

Alzheimers Disease Stem Cell Therapy Details
Overview
Alzheimer’s disease is a devastating process that affects the function, clarity and processes of the human brain. Comprised of multiple stages, Alzheimer’s disease is often first noticed as increasing frequency in forgetfulness, confusion and difficulty with thinking and reasoning processes. To date, no cure exists for the continually degenerative decline of those diagnosed with Alzheimer’s, which eventually incapacitates the brain’s ability to control body functions such as breathing, swallowing, and mobility. However, recent development in stem cell therapies offer hope for those diagnosed with Alzheimer’s disease.Treating Alzheimer’s DiseaseIn the past, Alzheimer’s disease, its processes, devastation and symptoms have become more widely known and understood, though medical doctors and researchers are still not certain what causes the condition. Medications such as Aricept, Exelon, Razadyne and Namendal are often employed to deal with the symptoms of Alzheimer’s, though they offer no hope for cure. Fetal stem cell research has been focusing on offering hope for relief of symptoms, improved clarity, body functions, and an eventual cure for multiple stages of Alzheimer’s. Fetal stem cell therapy is focused on restoring or maintaining specific brain function, as well as reducing further damage to brain cells and nerves. Such areas of study are currently underway in countries from Japan to the Ukraine. Treatment is most beneficial during the early stages of the disease process, when mental symptoms such as confusion, forgetfulness, and memory loss are first noted. In addition, fetal stem cell therapy has been shown to improve:

Appetite

Sleep Regulation of body weight

Overall physical conditions

In studies throughout Europe, individuals received two or three courses of stem cell treatments during the first year, followed up by additional course of stem cell therapy every year or two to maintain results.

To date, neural stem cells have shown a promising ability to repair memory in advanced stages of the Alzheimer’s disease process in mice, and blood stem cell growth factors proliferated through bone marrow derived cells is the focus of many therapies around the globe.

Who Benefits from Stem Cell Therapies for Alzheimer’s?

Individuals with a family history of Alzheimer’s, as well as those experiencing early onset symptoms of the disease process may benefit from stem cell research in countries where such therapies are approved and legalized. To date, the United States does not offer stem cell therapy, but clinical trials are currently underway. Stem cell therapies are currently available around the globe, from Mexico to Japan, South Korea, Germany, and the Ukraine, just to name a few. The treatment of Alzheimer’s disease is a major candidate for adult stem cell treatment, fetal stem cell treatment, and blood stem cell treatments offered as transplants that become integrated with DNA of cells and differentiate into specific types of neural cells.

Types of Stem Cells

To date, scientific research into stem cells has identified multiple types of stem cells and sources. The most commonly studied, and used, stem cell therapies today involve the use of:

Embryonic stem cell therapy

Adult stem cell therapy and research

Umbilical cord stem cell therapy

At their most basic definition, stem cells have the ability to limitlessly divide and are capable of developing into one or several different types of over 200 cells found in the human body.

Cost of Stem Cell Therapies for Alzheimer’s?

Cost of treatments or course therapy using stem cell technology and research is determined by geographic location of treatment facilities as well as the stage of Alzheimer’s being treated. Medical travelers are always cautioned to research and study human stem cell therapy, treatments and protocols and examine the history as well as case studies in foreign destinations.

Anti Aging Stem Cell Treatments Details
Stem Cell Anti Aging TreatmentsStem cell therapy is the new future for a variety of anti aging treatments. Studies underway and therapies offered throughout Europe have seen effective results through the use of fetal stem cells in reducing signs of aging, improving posture, mobility, and quality of life. Anti aging treatments, from reducing the signs of wrinkles to fighting free radical damage to enhancing memory, concentration, and quality of life are the focus of researchers around the world.

Types of Anti Aging Treatment

Many individuals seeking stem cell therapies for anti aging treatments are trying to undo the damage of years of sunbathing, tobacco or alcohol use, or wrinkles and damage caused by stress and overwork. One of the most popular types of anti aging treatments using stem cells utilizes a process involving fetal stem cell transplantation, which helps:

Regulate blood pressure

Normalize heart rate

Decrease levels of bad cholesterol in the blood

Increase brain and memory function

In addition, anti aging stem cell treatments may also be used to treat a variety of conditions and age related disease processes including:

Digestive disorders

Blood infections

Arthritis Lung conditions

Various forms of heart disease including hypertension

Chronic illnesses such as bronchitis

Fetal stem cell transplants utilized in the treatment of such conditions has shown positive effects within 3 to 6 months following stem cell transplantation. Improvements include decreased symptoms of disease processes, lowered blood sugar levels, blood pressure readings, and reduction in inflammatory and digestive distress. The regenerative properties and benefits of stem cells are the focus of multiple stem cell research facilities around the globe. The ability of stem cell therapy to help the body repair damaged areas has been even become the focus of many cosmetics manufacturers and markets around the world. Increasing amount of cosmetic formulas that utilize stem cell regenerative therapy are making their way onto the market, most commonly in the form of skin care creams and lotions. Umbilical cord stem cell therapy utilizes blood from umbilical cords following afterbirth of placenta after a baby is born. As a rich source of stem cells, cord blood stem cell therapy is making huge advancements today. Placenta Stem Cell Therapy is a fairly recent development in stem cell therapy research, doctors have been studying the beneficial components of stem cells found within the placenta, under study for its multipotent stem cells in the search for treatments of multiple illnesses and disease processes, including a large variety of aging processes.

How Does Stem Cell Therapy Effect Aging?

Fetal stem cells, adult stem cells, and umbilical cord stem cells have the ability to replicate and replace damaged cells and tissues in the body. This regeneration or restoration of healthy stem cells in the place of damaged, dying or dead cells restores functionality and vitality in the skin, organs, and tissues found in the body. Tissue engineering and stem cell research and technology is well on the way to enabling the medical community to grow skin, replace damaged or dead neural, muscular, cardiac and brain tissue. Stem cell based therapies are now focused on engineering adult stem cells, umbilical cord stem cells, and fetal stem cells to develop or morph into the type of tissue necessary to restore optimal function and quality of life.

Selecting a Stem Cell Provider

When choosing a stem cell provider, research the topic, the procedure and the facility. Ask a variety of questions, including: Can you offer proof that these stem cell therapy treatments work? Can I speak with former patients who have undergone such therapies? Who are (and what are the credentials) of the physician or surgeon administering stem cell therapies or treatments? How long has the organization offered such treatments? How safe is the treatment? Are there risks involved?

Arterial Hypertension Treatment with Stem Cell Details
Treating Arterial Hypertension Through Stem Cell TherapyHypertension is a potentially devastating medical condition that increases blood pressure. Known as a silent disease, hypertension generally doesn’t involve symptoms that are easily recognized by most individuals until damage to blood vessels or cardiac health is realized. In most cases, hypertension, also called arterial hypertension, is treated with a variety of drugs that may involve the use of diuretics, Beta blockers, ACE inhibitors, and calcium channel blockers. However, research into stem cell therapies that may help reduce or reverse symptoms of hypertension are currently under study in a variety of stem cell research facilities around the globe. Basically defined as elevated blood pressure, arterial hypertension places added strain on the heart muscle in providing adequate flow of oxygen rich blood to all the body’s tissues and organs. In some cases, the transplantation of embryonic stem cells may help provide relief, reducing blood pressure and the need for hypertensive therapy treatments. To date, embryonic stem cell treatments for hypertension have shown efficacy in reducing blood pressure, frequency of headaches, and a stabilization of blood pressure, leading to enhanced mental capacity and abilities, rejuvenation, and sexual performance and potency in men and women. A variety of facilities throughout Europe, the Netherlands, and Ukraine have offered and performed treatments, clinical trials and studies regarding the efficacy of stem cell therapies to improve heart function. Studies performed in the Netherlands have shown that allogenic stem cell therapies improved function of the right ventricular portion of the heart as well as lung capacity in small animals with pulmonary hypertension. Embryonic stem cells have the ability to differentiate, or become any type of cell in the human body, offering unique opportunities to replace damaged cells and tissues in the human body. Replacing damaged cells with healthy cells is the foundation of stem cell transplantation and implantation therapies and treatment studies. Researchers believe that some types of stem cells found in the body may contribute to the thickening of blood vessels, leading to various types of hypertension, including pulmonary hypertension. Other researchers believe that embryonic or other progenitor stem cells have the capability of repairing damaged blood vessels and tissues, restoring normal blood flow throughout the body and to the lungs. Healthy stem cells are cultivated in a laboratory environment and then injected or transfused into a person suffering from arterial or pulmonary hypertension. While the technology is still very new, it is an area of intense and concentrated research in stem cell research facilities around the world. According to the Pulmonary Hypertension Association, the use of stem cell therapies for PAH (pulmonary arterial hypertension), also known as primary pulmonary hypertension, has shown promising benefits. Clinical trials are under way in the United States and Canada, while stem cell therapies conducted around the globe have also shown promising results.
Bone Marrow Stem Cell Therapies Details
OverviewBone marrow transplants are not new. They have been used to treat conditions such as leukemia since the late 1960s. However, only in recent years has the general public gained a greater understanding of the benefit of stem cells found in bone marrow and how they can be used to treat a multitude of conditions. Recently, bone marrow transplants, commonly known as BMTs, have been researched as treatments and potential cures for several types of cancer including Hodgkin’s and non Hodgkin’s lymphoma. Common cancer treatments such as chemotherapy and radiation are designed to destroy cancerous cells, tumors and growth. Unfortunately, these same treatments also damage and destroy healthy cells along with the bad ones. Bone marrow is a spongy type of tissue found in the center of bones and creates blood cells, including important leukocytes (white blood cells) vital for fighting multiple types of infection. Bone marrow is a source of rich supplies of stem cells, the most common location for harvesting such cells being the pelvic bone. Bone marrow transplantation has been used to replace damaged bone marrow in patients who have undergone high-dose chemotherapy or radiation therapy.

Types of Bone Marrow Transplant

In medical conditions where bone marrow is healthy, common practice has been to withdraw healthy bone marrow from a patient and freeze it. The patient undergoes chemotherapy or radiation therapy to treat the cancer. Following the chemotherapy or radiation procedures, the bone marrow is thawed and then replaced in the body of the individual through a needle inserted into a vein. This type of transplantation procedure is called autologous transplantation, which means that the marrow or cells came from the same individual receiving treatment. Another common type of transplant is called the allogenic, which means the bone marrow has been taken from a different individual, to later be injected into the patient.

A peripheral blood stem cell transplant (PBSCT)

is another common method of an autologous transplant that involves the patient’s blood being passed through a machine that processes and removes stem cells from the blood and then returns them to the body. A peripheral blood stem cell is defined as one that circulates within the body, such as those found in blood. Stem cells are immature cells from which multiple types of blood cells can form. For example, as stem cells may be convinced to form into muscle tissue, cardiac tissue, skin tissue, or liver tissue and so forth. This type of peripheral blood stem cell transplant is called apheresis, a procedure that generally takes up to 4 hours, and is the most common method used today to collect stem cells for transplants. The third technique for bone marrow transplants is called a synergeic procedure. However, this method is only used in the case of bone marrow transferred from one identical twin to the other, and is fairly rare.

The Bone Marrow Transplant Procedure

The bone marrow transplant procedure, except in the case of an autologous technique, involves two people – the bone marrow stem cell donor and the recipient. The donor receives an anesthetic that puts him or her to sleep. Several long needles are inserted into the iliac crest (the back of the pelvic bone) to remove bone marrow. Bone marrow is a thick, liquid substance that may be suctioned into a needle. Risks to donors are minimal and involve general soreness at the site for several days following the procedure. The collected bone marrow is filtered and kept within a solution and stored in a frozen state with liquid nitrogen. Prior to use, it is thawed and injected in a process similar to a blood transfusion. The injected bone marrow cells travel through the recipient’s bloodstream to the bone marrow, where they begin to create healthy blood cells. In most cases, new blood cell development conditions are usually noted within 2 to 4 weeks.

Who Benefits From Bone Marrow Stem Cell Therapies?

In the past, bone marrow transplants were limited to use for treating leukemia. Today, bone marrow stem cell therapies are being used to treat other conditions such as lymphoma and heart disease. Because the bone marrow stem cell supply provides unlimited stem cells that may be utilized for treatment of other medical conditions and disease processes, and involves minimal risk to individuals, such techniques are likely to grow in popularity in the coming years.

How Much Does a Bone Marrow Stem Cell Transplant Cost?

In the United States, an autologous bone marrow stem cell transplant will not cost as much as one that involves another individual. For individuals who must find a donor, costs for that search alone may range between $10,000 and $25,000. Following that, compatibility testing must be performed. The collection of stem cells may cost between $3,500 and $5,000 for related donors, though costs may rise to $15,000 to $50,000 dollars for unrelated donors. For an autologous transplant, costs for an individual may range between $50,000 and $100,000, while allogenic transplant may range between $150,000 and $200,000 for the recipient. Patients traveling to international destinations may save tens of thousands of dollars or up to 70% on stem cell treatments and therapies. Travelers to India may pay approximately $26,000 for a bone marrow stem cell transplant.

Who Performs Bone Marrow Stem Cell Transplants?

A doctor specializing in oncology or a bone marrow transplant doctor or surgeon will engage in bone marrow transplant therapies. Oncologists and transplant doctors and surgeons should be trained, certified and accredited through country of origin or international accreditation and certification boards and should also belong to organizations or associations of their specialty.

Cancer Treatment with Stem Cell Details
Finding Cures for Cancer with Stem Cell TreatmentsThe search for cancer cures has been ongoing for decades. A diagnosis of cancer was once a death sentence for millions, and in the 21st century, there is still no cure. However, thanks to modern technology and diagnostic imaging and equipment, more people diagnosed with cancer are not only beating the disease, but outliving it. Some of the greatest advancements in cancer research and therapy have involved studies of stem cell transplantation for replacing erratic growth of cancerous cells, tissues and tumors in the human body. Today, stem cell research facilities around the world are patenting their own treatments and therapies for cancer programs, one of the most popular and effective being the transplantation of embryonic or fetal stem cells at all stages of the disease process. To date, most types of cancer have been treated through traditional therapies involving surgery, chemotherapy, radiation, or a combination of all three. Unfortunately, chemotherapy and radiation bring with them severe and often debilitating side effects such as nausea, vomiting, weakness, anemia, and depression. Stem cell therapies have been shown to improve the body’s ability to withstand devastating chemotherapy and radiation treatment therapies that may kills cancer cells, but also damage and destroy healthy cells in the body at the same time. To date, embryonic stem cell therapies and implants into patients receiving chemotherapy and radiation in the Ukraine show improvement of the side effect symptoms of such cancer therapies as well as help to restore the body’s immune system following irradiation treatment procedures. It is also understood that many stem cell therapies aid in the creation of anti-tumor immunity that may very well inoculate the individuals from further cancers in the future.

Targeting Cancer Growth

Stem cell researchers and medical professionals around the globe are studying a variety of stem cells and how they may be used to treat various forms of cancer. The University of Rochester is focusing on normal stem cell development and cancer stem cell growth in order determine the most effective methods of destroying cancerous stem cells and tumors without damaging healthy cells and tissues surrounding them. Gene therapy and genomic research is also an important aspect of targeting cancer cells; their creation and proliferation, and tumor growth. Embryonic and hematopoietic stem cells offer self- renewing stem cells for implantation or transplantation into cancer patients that replaces damaged or dead cells and tissues caused by erratic cancer growth. The University of Michigan Comprehensive Cancer Center is just one of the few in the United States engaging in research and studies in targeting and destroying cancer stem cells that may offer stem cell therapies and treatments for many different types of cancer, including Hodgkin’s disease, leukemia, breast cancer, prostate cancer, and testicular cancer, among many others. Therapies and treatments utilized in the Ukraine, Australia, Asia and Latin America are focusing on eliminating cancer stem cells from the body before they metastasize, or spread, to other parts of the body. Stem cell research in cancer therapy treatments is nothing new, but the approaches to treating symptoms and targeting cancerous cell growth, and restoring health and wellness through stem cell implants, injections and therapies is just in its beginning stages. Stem cells utilized to replenish blood and boost immune system function following cancer treatments has proven beneficial, but the next step in cancer therapies is to destroy cancerous cell growth and substitute damage cells through the injection of healthy stem cells. Nothing less than total remission is acceptable for stem cell researchers and developers, and their studies will continue until such a goal is not only possible, but proven.

Cerebral Palsy Stem Cell Therapy Details
Stem Cell Therapies to Treat Cerebral PalsyCerebral Palsy defines a variety of physical manifestations related to movement and posture. Originating in the brain, Cerebral Palsy causes muscles to be stiff or rigid, or weak and uncontrolled. Affecting children who carry the condition into adulthood, cerebral palsy may also cause vision problems such as depth perception, lack of balance, as well as uncontrolled muscle movements, or a combination of all the muscular and neuro manifestations mentioned above. In some cases, toddlers or small children diagnosed with cerebral palsy may overcome their symptoms as they age, but many others suffering from moderate to severe forms of the condition must live with their symptoms for their entire life. Cerebral palsy is caused by some form of damage or injury to the brain, often occurring during development or the birthing process.

Therapies for Cerebral Palsy

No cure has been found to permanently treat the disabilities and manifestations of symptoms of Cerebral Palsy in children or adults. However, stem cell research and technology focusing on umbilical cord stem cell therapies in the treatment of Cerebral Palsy have been under study in recent years. The focus of such studies is to integrate transplanted stem cells into injured areas of the brain, restoring lost function and mobility. To date, the most traditional and alternative therapies for treatment of Cerebral Palsy include: Physical therapy Drug therapies (Klonopin, Dilantin, anti-seizure medications, Botox, Baclofen, Tegretol) Surgery Magnetic Therapy – (Magnetic Molecular Energizing – MME) Amino Acid Therapy Stem Cell Therapies (embryonic stem cell lines, umbilical cord stem cells, germ-cell-derived stem cells) Many stem cell therapies focus on reducing spasticity in the muscles.  Stem cell therapies such as those called CD 34+ and CD 133+ have been used for about a decade. Very specialized stem cells that have shown promise in migrating to and repairing white matter brain damage, such stem cell therapies injected into those experiencing a variety of cerebral palsy symptoms have enjoyed fairly promising outcomes.
Who Benefits From Stem Cell Therapy Targeting Cerebral Palsy?

Children experiencing a lack of muscle tone, the ability to breathe properly, swallowing difficulties, immunodeficiency, and difficulty with movement, including lack of balance, difficulty walking, and using fine motor skills may benefit from stem cell therapies targeting certain areas of the brain that affect movement and function. Repeated stem cell injections may be necessary, through subcutaneous or intravenous injection.

How Much Do Cerebral Palsy Stem Cell Therapies Cost?

Whilst clinical trials for stem cell therapies are underway in the United States, the FDA has not yet approved stem cell treatments in the United States. However, the prospective costs of stem cell therapies range between $10,000 and $50,000, depending on the type of stem cell, frequency of injections, and length of therapy. Facilities around the world, including those found in Mexico, Europe, and Southeast Asia are able to offer stem cell therapies, including umbilical cord derived stem cells, for an average of about $8,000 a vial, with prices decreasing as the number of vials needed increases.

How Do I Select a Stem Cell Provider? Ask questions:

Can you offer proof that these stem cell therapy treatments work? Can I speak with former patients who have undergone such therapies? Who are (and what are the credentials) of the physician or surgeon administering stem cell therapies or treatments? How long has the organization offered such treatments? How safe is the treatment? Are there risks involved? Many facilities worldwide offer stem cell therapy, but it’s important to locate accredited and experienced physicians who deal with stem cell treatments. Doctors specializing in oncology or neurodegenerative disease processes should be trained, certified and accredited through country of origin or international accreditation and certification boards and should also belong to organizations or associations of their specialty. Check references and resources to determine whether physicians or specialists are trained, experienced and accredited with placenta stem cell therapy treatments with his or
her country of origin and that facilities provide state-of the art technology and equipment and have a well maintained, trained and educated staff.

Embryonic Stem Cell Therapy Details
Embryonic Stem Cell BasicsWhen many people hear the words ’embryonic stem cells’, they immediately cringe, believing that developing embryos and fetuses are being destroyed for the pure purpose of scientific research. Embryonic stem cell research has been going on for decades, and has always been shrouded with controversy based on religious and moral beliefs and opinions. Understanding embryonic stem cells, how they’re collected, and how they’re used will perhaps provide greater understanding for individuals wishing to determine what the controversy is all about.

How Are Embryonic Stem Cells Collected?

Embryonic stem cells are derived from embryonic tissues. In most cases, embryonic stem cells are created or procured from embryos that have been developed from eggs fertilized through in-vitro fertilization procedures, but what most people don’t know or realize is that many of them are donated for research purposes with informed consent of the donors. It should be stated unequivocally that embryonic stem cells are not taken from eggs fertilized within a woman’s body. Embryonic tissues and cells are generally collected four to five days after fertilization occurs in cell cultures grown in laboratories. Embryonic cells grown in the laboratory settings (in culture mediums) divide and spread over the surface of petri dishes. Today, research and development of embryonic stem lines is still not perfected, and small numbers of embryonic cells must be cultured, divided and multiplied repetitively to produce adequate amounts of embryonic stem cells for research at laboratories around the world. In many cases, this process takes up to six months or more. Stem cells that have not differentiated, or grown into specific types of cellular tissues are called pluripotent. This long process of generating an adequate number of embryonic stem cells results in batches of cells that are able to be frozen and then delivered to laboratories for future research and development. Undifferentiated, or unspecified embryonic stem cell cultures may be gently coerced through scientific methods to form into different types of cells, including nerve cells, muscle cells, and cardiac or heart muscle cells.

Ethics and Embryonic Stem Cell Research

Embryonic stem cell research will more than likely continue to be embroiled in moral and ethical debates regardless of the fact that researching and studying their potential forhealth and medical research may very well provide treatments and cures for disease processes such as Alzheimer’s, Parkinson’s, leukemia, other cancers, and forms of diabetes. Understanding stem cell development and how it relates to future potential treatments and methodologies is essential in the efforts of scientists and researchers to find cures or not only terminal illnesses, but to reverse the effects of physical injury, but also spinal cord and neural damage caused by accidents and disease processes as well as cardiac or stroke damage. Human embryonic stem cell research offers the best use of pluripotent stem cells, or stem cells that may eventually develop into many different types of cells, found in the body, and may in the near future become a fully acceptable avenue of research and development as its importance in such treatments is discovered and discussed. Education and exploration in religious, ethical and scientific fields may help individuals reach an understanding that offers compassionate and moral use of such tissues.

Embryonic Stem Cell Research and Treatment of Human Diseases

Embryonic stem cell research has been used for the treatment of human diseases for many years. Since the late 1990s, the University of Wisconsin, among other stem cell research facilities in the United States and around the world, have developed techniques to isolate and grow certain types of stem cells for medical research. As of 2009, one California-based stem cell research company has received clearance by the FDA (Federal Drug Administration) to begin the first human clinical trials of stem cells derived from human embryonic tissues. The potential of embryonic, adult stem cell, placenta and umbilical cord stem cells in the treatment of human illnesses and disease processes including diabetes, kidney disease, cancers, mental disease processes such as Parkinson’s and Alzheimer’s as well as in cardiac care, and spinal cord injury treatment is unlimited.

The Future of Stem Cell Research

The potential use of stem cells may help to reduce and even prevent birth defects, cancers, muscular and neural diseases such as multiple sclerosis, osteoporosis and arthritis and will continue to offer doctors, scientists and researchers around the world hope for the future development of treatments and procedures that will increase quality of life, treat or cure formerly incurable disease processes and restore movement to those who have been paralyzed through injury or disease.

Epilepsy Details
Stem cell therapies and technologies are gaining more acceptance around the globe as the efficacy and benefits of a variety of stem cell treatment approaches to chronic disease conditions, injuries, and other illnesses become apparent. One of the most controversial types of stem cell research, but one of the most effective, is the use of embryonic stem cells in devising treatments or therapies for a variety of ills. Contrary to popular opinion however, embryonic stem cells are not taken from live fetuses, babies, or in any other way hurt or harm a fetus, infant, baby, or the mother. Rather, most embryonic stem cells are cultivated from donations made by women who have undergone successful fertilization treatments and therapies. Embryonic stem cells have the unique capacity to develop into any type of cell in the human body; blood, bone, brain tissue, liver tissue, skin tissue, etc.. Embryonic stem cell research can help regenerate and restore damaged brain tissue, making it an extremely viable therapy for individuals diagnosed with various forms of the epilepsy.Stem Cell Therapies for Epilepsy

Scientists and researchers have studied and determined that neuron precursor cells taken from embryonic stem cells can be transplanted or implanted into brain tissue and generate new brain tissues in that area. Over 80 nations have conducted studies and experiments in this field, which has led to positive results expressing hope for extremely effective therapies for improving brain function not only with individuals diagnosed with epilepsy, but those diagnosed with Parkinson’s and Alzheimer’s disease as well. Studies in Germany have focused on transplantation of embryonic stem cell derived neuron precursor cells into the central nervous system for improved symptoms and brain function of epilepsy patients. While such technologies are still in their infancy, studies have shown promise in the ability of embryonic stem cells to migrate into various regions of the brain as well as process and receive signals from that person’s brain. Stem cell therapy studies have also noted that stem cell implantation or transplants into the brain help to repress the number and severity of seizures that people diagnosed
with epilepsy may experience, offering a new approach to therapies offered for epilepsy. Such studies show promise for individuals who don’t respond well to traditional prescriptive anti-seizure medications. Umbilical cord and placental stem cells are also viable options for treating epilepsy. Studies throughout Mexico, Latin America, Asia and Europe are also following such avenues in their research, studies, and clinical trials. Research has determined that a component called adenosine, which can be received from stem cell implants, helps to suppress
seizures, and the transplantation of GABA-producing (gamma-Aminobutyric acid) stem cells may be utilized for those diagnosed with intractable seizures, or seizures that are difficult to control.

Future of Stem Cell Treatments for Epilepsy

Scientists and researchers are focusing on neurogenesis, or the production and proliferation of new and healthy neural cells in the brain and central nervous system to help alleviate symptoms of epilepsy in millions of individuals around the world. Current studies have determined that therapies and studies underway may have extreme beneficial effects on epileptic syndromes, and studies will certainly continue into the future in regard to learning and understanding regeneration or neurogenesis of brain cells and tissues that may help alleviate, reduce, and even someday cure epilepsy syndromes found in most children and adults.

Liver Stem Cell Therapies Details
OverviewThe liver is a large, glandular organ of the body that offers a wide range of functions, including protein synthesis, detoxification, digestion and metabolism in the human body. A variety of injuries and disease processes to the liver severely hamper the body’s ability to perform at optimal levels. Some of the most common disease processes that affect liver function include:
Hepatitis Alcoholism (a major cause of cirrhosis of the liver) Cancer Common pediatric or childhood diseases of the liver include:

Langerhans cell histiocytosis

Biliary atresia

Alagille Syndrome

Progressive familial intrahepatic cholestasis

The liver is also the only organ capable of regenerating lost tissues, and even a small portion of liver can eventually regenerate into a entire liver. Because of this ability, the liver is uniquely receptive to a variety of stem cell treatments and technologies.

Stem Cell Research Affecting Liver Diseases

Since the early 1990s, EmCell, a Ukrainian stem cell research facility has offered suspended fetal stem cells in clinical practice and implantation of stem cells for treatment of liver cirrhosis. Fetal stem cells are then administered through IV (intravenous) injection through endoscopic or laparoscopic implantation in patients diagnosed with cirrhosis of the liver or chronic hepatitis. This technology utilizes a combination of hematopoietic stem cells and embryonic liver cells (commonly taken from leftover embryonic cells from fertility treatment patients or
from previously aborted fetuses) to help restore function and health in damaged liver tissues.
Another common approach to treating liver disease processes is through adult liver stem cells, due to their ability to regenerate injured liver tissues. The potential for such stem
cell replacement therapies is under study at the University of Pennsylvania School of Medicine, and focuses on individuals whose livers can no longer repair their own tissues.
Such treatments and technologies may help reduce the number of individuals around the world waiting for liver transplants. Researchers throughout the globe are studying the
ability of duel- potential stem cells that have been isolated from healthy liver cells and express a certain protein necessary for regeneration. Currently, the University of Pennsylvania Institute for Regenerative Medicine and the Penn Center for Digestive Diseases Center are continuing research in this area. In other areas of research, chronic liver disease treated through CD34+ stem/progenitor cell populations injected into the blood has shown positive and promising results. Stem cell research continues in the hope of understanding the pathogenesis of liver disease and the production of stem cells derived from embryonic stem cells and bone marrow to
produce liver-like cells. Billions of dollars of research monies have been granted to stem cell research facilities around the globe, from California to Pennsylvania, the Ukraine, Japan, Germany and France.

Cost of Liver Stem Cell Therapies

The cost of therapies is determined according to geographic location of treatment facilities as well as the injury, illness or disease being treated. Currently, no stem cells therapy options are available in the U.S., which prompts many Americans to venture to international destinations for them. The potential cost of stem cell therapies in the U.S. may be prohibitively expensive, which encourages those hoping and seeking cures for illnesses, injuries and disease processes to travel to China, Thailand, Japan, Europe, and India, among others.

Multiple Sclerosis Stem Cell Treatment Details
Hope For Future MS PatientsMultiple sclerosis is an insidious auto-immune disease process that destroys the myelin sheaths, which surround axons of the brain and spinal cord. Axons are the main “freeway” of nerve signals that control muscle function, movement, and cognitive abilities. Multiple sclerosis is also known as MS, a condition that literally causes the body’s immune system to attack and destroy its own myelin sheaths, which prevents axons from receiving and sending out signals. Multiple sclerosis can either be a relapsing form of the disease or progressive form of the disease. In the relapsing form of MS, symptoms may peak and ebb, such as waves in an ocean tide, with long periods of inactivity in between episodes. The progressive form of the disease causes a general increase of symptoms and neurological problems as the disease advances.

Stem Cell Research and MS

Large strides have been made in the use of stem cell therapy, re-implantation and transfusion to help treat and alleviate symptoms caused by multiple sclerosis. Several stem cell research and treatments facilities, among them EmCell, located in Ukraine, have reported improved quality of life and relief of symptoms of patients diagnosed with the relapsing form of the disease process. Even patients diagnosed with the progressive form of the disease have been treated with a nearly 60% success rate through fetal stem cell transplantation. Patients followed for approximately 5 years post-treatment showed a definitive regression of neurological symptoms following stem cell transplantation, with neuro muscular improvement, decreased weakness, and enhanced mental outlook in approximately 93% of patients. According to studies in the EmCell facilities, patients showed:

Improved eyesight

Improved mental capacity

Improved ability to concentrate

Improved neuromuscular function

Broken down even further, EmCell stem cell research and treatment facility followed 18 multiple sclerosis patients and recorded neurological symptoms for years after treatment in the areas of: Deep reflexes

Abdominal reflexes

Dysphagia

Pathological plantar reflexes

Coordination tests Gait

Self care capacity

Before fetal stem cell transplantation, patients were rated at a scale of 10, and four years after the transplant should definitive improvement (ranging in scores from 1 to 6) in coordination, self care capacity, muscle control, deep reflexes and abdominal reflexes. In the United States, Northwestern University in Chicago and other medical universities throughout the country are conducting clinical trials using patients own stem cells (autologous) to treat symptoms of multiple sclerosis with promising results. Stem cell transplantation utilizes stem cells from various sources to be stimulated into growing new, healthier cells which are then harvested and transplanted or re-infused into the person afflicted with multiple sclerosis. To date, scientific research into stem cells has identified multiple types of stem cells and sources. The most commonly studied, and
used, stem cell therapies today involve the use of: Embryonic (fetal) stem cell therapy Adult stem cell therapy and research Umbilical cord stem cell therapy

How Much do Stem Cell Treatments Cost?

Stem cell treatments in the U.S. in the future are projected to be $25,000-$50,000 depending on the type of stem cell therapy utilized, the disease being treated and the method of therapy, including stem cell transplantation and number of sessions necessary. Prices in China are generally about $40,000 and placenta stem cell treatments in India and Mexico range about $25,000. Facilities in Central Europe also offer stem cell treatment cycles for substantial savings over projected costs in Western Europe and the U.S. in the future.

Choosing a doctor for Stem Cell Therapy Treatments

Many facilities worldwide offer stem cell therapy, but it’s important to locate accredited and experienced physicians who deal with stem cell treatments. Doctors specializing in oncology or neurodegenerative disease processes should be trained, certified and accredited through country of origin or international accreditation and certification boards and should also belong to organizations or associations of their specialty.

Muscular Dystrophy Treatment Through Stem Cell Details
Potential Treatment for Muscular Dystrophy Patients Through Stem Cell Therapy
Muscular dystrophy, also known as MD, is a muscle disease that is often passed from one generation to the next. The condition involves a gradual weakening or damage to
muscle fibers of the voluntary muscles, such as those that control walking, bending, turning and lifting. Several types of muscular dystrophy damage not only connective tissues
in the extremities, but may damage the heart muscle, as well as involuntary muscles such as internal organs. Muscular dystrophy is believed to be caused by a deficiency of a protein called dystrophin, essential for muscle growth and function. This deficiency is often genetic for many
individuals. To date, medications to treat muscular dystrophy are generally designed to help reduce symptoms of muscle spasms, muscle weakness and stiffness, while anti
inflammatory corticosteroid medicines such as prednisone are often given to help improve muscle strength. In some cases, drugs that suppress immune system function offer some help in slowing dying muscle cell damage. Today, therapies utilizing embryonic stem cells for implantation or transplants may offer more effective benefits to muscular dystrophy patients than drug therapies, physical therapy, or assistive devices such as canes, walkers and wheelchairs. The most common type of muscular dystrophy is called Duchene’s, but there are a half dozen others that affect a variety of muscles in the body in different ways. Duchene’s muscular dystrophy is linked to a genetic disease process caused by a mutation in the dystrophin gene. Dystrophin is necessary for health and growth of cells and is responsible for stimulating muscles and muscle function and movement. Stem cell research is focusing on restoring levels of dystrophin in patients diagnosed with Duchene’s muscular dystrophy. While there is no cure to date for muscular dystrophy, stem cell research and implantation of healthy embryonic cells into individuals diagnosed with various forms of muscular dystrophy may improve function and mobility as well as slow the muscle-wasting process.Clinical Studies Under WayCurrently, clinical studies and trials utilizing a variety of stem cell approaches are under study around the world. A stem cell research facility in the Ukraine has treated nearly 400 patients with stem cell therapy and is following their progress. Currently, observations have determined that stem cell transplantation considerably reduces the progression of the disease process at all stages, and enables patients to enjoy deeper reflexes, internal organ function, and physical and mental activities. Benefits to long term health and wellness following embryonic stem cell transplantation is an ongoing endeavor, with patients so far required to receive stem cell replacement therapy approximately every 6 to 8 months. The University of Colorado at Boulder has been able to specifically identify a muscle stem cell that may be utilized to restore and revitalize muscle tissues damaged by muscular dystrophy, while in Australia, researchers at the University of New South Wales are focusing on regenerating damaged tissues that may help individuals suffering from the ravaging muscle wasting processes of muscular dystrophy and myopathy. Researchers throughout Ukraine, Australia, Italy, and the United States have focused on stem cell therapies for individuals diagnosed with limb-girdle muscular dystrophy, which causes a slower but gradual increase in muscle weakness. Research, clinical trials, therapies and treatments in stem cell implantation and transplants will continue in this field as researchers around the globe search for greater
understanding of the best type of stem cells to be utilized in treating all forms of muscular dystrophy, offering hope to millions affected with the muscle wasting disease.
Parkinsons Disease Stem Cell Treatment Details
OverviewParkinson’s disease is a disorder of the motor system, affecting muscle movement. Common symptoms of Parkinson’s disease include trembling of the hands, tremors, stiffness of the limbs and torso, and slow, stiff movements. Individuals diagnosed with Parkinson’s may also have difficulty maintaining balance and exhibit poor coordination. Parkinson’s disease generally affects people over 50 years of age, though the symptoms of the developing disease occur gradually. For years, treatment of Parkinson’s disease has been focused on relieving symptoms through the use of the drug known as Levodopa, often combined with Carbidopa. Because the disease is caused by reduction or loss of brain cell that produce and release dopamine, nerve cells can use Levodopa to encourage dopamine production in the brain. However, while some people respond positively to the drug, others do not. New drugs and treatments are currently under research, including stem cell therapies.

Fetal Stem Cell Therapy Research for Parkinson’s Disease

Researchers have fairly recently identified that exposure to a variety of neurotoxins as well as genetic dispositions may often determine the possibility of an individual contracting Parkinson’s later in life. Changes in dopamine levels, metabolic changes, and other signs may lead to early diagnosis of the disease process. To date, several stem cell therapies have been used in the treatment of Parkinson’s disease, including those utilizing fetal stem cells. Identification, treatment, and prognosis of Parkinson’s symptoms and conditions depends on the degree or stage the disease is in when the individual is first diagnosed. Parkinson’s disease is broken down into six stages, from mild or early Parkinson’s (Stage I) to Stage VI, where an individual has extreme difficulty standing or walking. Stem cell research facilities in Central Europe treating Parkinson’s with fetal stem cells have noted effectiveness in nearly 85% of cases, helping improve balance, reduce tremors, relieved rigidity, and slow the progression of the disease process. Individuals treated after Stage III have received approximately 65% to 70% effectiveness of therapy through stem cell treatments, according to EmCell, a leading stem cell research and stem cell therapy provider in the Ukraine. In addition to improved physical symptoms, individuals treated at EmCell with fetal stem cells, patients in the study showed distinct psycho-emotional improvement as well as maintenance of memory and intellect, speech patterns, improved thinking skills, and more positive emotions.

Adult Stem Cell Therapy Research

Another focus in stem cell therapy for symptoms and treatment of Parkinson’s disease includes the use of adult stem cells, more specifically adult neural stem cells. As an autologous stem cell, such cells (at its most basic definition) are taken from the individual, multiplied, and reinserted into the patient. Clinical trials utilizing autologous neural stem cells for Parkinson’s disease treatment are underway in the United States, and have so far been deemed safe and therapeutic, according to results published by UCLA researchers in the Bentham Open Stem Cell Journal. “We have documented the first successful adult neural stem cell transplantation to reverse the effects of Parkinson’s disease and demonstrated the long-term safety and therapeutic effects of this approach,” stated Dr. Michel Levesque, author of the article, published in 2009. Patience progress was observed for five years following the procedure, displaying and 80% improvement in motor skills and scales for at least 36 months following treatment. Additional clinical trials are underway to replicate the findings.

Future of Stem Cell Therapy for Parkinson’s

Because of its morphology, Parkinson’s disease is fairly receptive to stem cell transplantation therapies, which basically utilizes the process of substituting healthy dopamine producing brain cells for those that are dead or dying. Stem cells research facilities around the globe are currently undergoing clinical trials, patient trials and recording results. While stem cell therapy has not yet been approved in the United States, they are available in a variety of locations throughout the globe from Central Europe to Latin America to Asia and, of course, the clinical trials underway in the United States, offering hope to millions of Parkinson’s patients.

Placenta Stem Cell Therapy Details
Brief OverviewOne of the most important factors of newborn development is the placenta, the ‘sac’ that protects and provides a liquid-filled home for a developing fetus. During pregnancy, the placenta serves as important protection, growth, development and nourishment (via the umbilical cord) of vital organs such as the lungs, liver, kidneys, immune system and digestive system while such organs are developing within the fetus itself. With new scientific technology, there has been a discovery of unique multipotent stem cells to be found within the placenta. Such cells found within placental tissues have been shown to treat such diseases as, among many others: Parkinsons and Alzheimers disease, auto-immune disorders, stroke, lupus. muscular dystrophy and cerebral palsy. While the stem cell controversy is still up for debate, many find that the use of placenta stem cells morally acceptable and ethical because the newborn babies no longer need them after birth. Placenta tissues and afterbirth have been discarded in the past. In addition, acquiring placental stem cells causes no harm to the fetus or embryo or mother. The placental stem cells are harvested after the baby is born via cesarean section so that the placenta does not receive contamination through a traditional birth.

Placenta Stem Cell Therapies and Treatments

Placenta stem cell treatments are uniquely determined based on medical need or condition. A physician will review the patients medical record and decide where to place the stem cells during a patient consultation. Determining where to put the stem cells is vital to offer the greatest impact on the patients condition and generate the best results as possible. Placenta stem cell therapy has been utilized for more than twenty years in Europe for treatment of multiple disease processes with promising results. Once the administration sites are determined, the patient is given a local anesthesia at the implant site. Many patients find the treatment painless. One such technique to implant placenta stem cells was devised by Dr. Omar Gonzalez of the Integrative Medical Center in Mexico. Once the anesthesia has begun to work, the physician then makes small incisions in which to place the placental stem cell implants. The placental tissue is placed within the incision and then closed up with a suture. Results to the stem cell implants are seen anywhere from 24 hours, though it takes about six months to one year for the placental tissue to be fully absorbed by the body. The physician might also decide to give stem cell injections at different locations on the body to increase the positive effects of the implant procedure.

Benefits of Placenta Stem Cell Therapies

Undergoing stem cell therapy is ideal for anyone who suffers from numerous medical issues or ailments and has not seen results in other methodology treatment plans. Painless and effective, placental stem cell therapy has been shown to drastically improve many medical conditions. For those who might find the use of stem cells to be a debatable issue, many ethicists and physicians agree that placental stem cells are ethical since the newborn baby no longer needs it, and it is traditionally discarded after birth. Stem cells offer a renewable source of new cells for the body to replace and treat many medical issues such as those listed above. Cost of Placenta Stem Cell Therapies Stem Cell therapy treatments are not yet approved in the United States, so individuals wishing to enjoy the benefits of treatment of any type of stem cell technology must venture outside American borders. However, such treatments in the U.S. in the future are projected to be $25,000-$30,000 depending on the number of implants, while in China prices are generally about $40,000 and placenta stem cell treatments in India are approximately $25,000. Costs in Mexico are competitive. For those who wish to undergo stem cell therapy through medical tourism, costs usually include travel expenses and any additional medical attention needed.

Choosing a doctor for Stem Cell Therapy Treatments

Many facilities worldwide offer stem cell therapy, but it’s important to locate accredited and experienced physicians who deal with placenta stem cell treatments. Check references and resources to determine whether physicians or specialists are trained, experienced and accredited with placenta stem cell therapy treatments with his or her country of origin and that facilities provide state-of the art technology and equipment and have a well maintained, trained and educated staff.

Spinal Muscular Atrophy Therapy Through Stem Cell Details
Treating Spinal Muscular Atrophy Through Stem Cell TherapySpinal muscular atrophy, more commonly known as SMA, afflicts millions of individuals around the world. Considered a neuromuscular disease, the condition causes a degeneration or destruction of motor neurons, which transmit signals from the brain to the muscles. The condition causes eventual atrophy or wasting away of muscles throughout the body, and can affect all age groups and genders. Muscle weakness, impaired movement and range of motion are the most common symptoms of SMA, caused by the inability of motor neurons from the spinal cord to reach the muscles. Patients may experience relatively minor symptoms to fatal symptoms, depending on the stage and manifestations of the disease process in any given individual. While there is no known cure to date for SMA, stem cell therapies and technologies have shown positive results in treating a variety of symptoms associated with the condition. Gene replacement and stem cell replacement therapies involving the implantation of healthy and completely functional motor neurons into individuals diagnosed with the condition are showing promising results, especially in the increase of the production of the specific SMN 2 gene responsible for healthy motor neuron development. Stem cell research facilities in treatment centers around the world have begun treating SMA symptoms with embryonic stem cell transplants and implantation therapies, offering remission in up to 75% of cases, as well as helping to diminish the symptoms of neurogenic dystrophy in patients in 90% of cases in some clinical and treatments studies. Clinical trials in stem cell treatments and therapies for spinal muscular atrophy are focused on determining efficacy data, assuring safety, and quality assurance in the implementation of testing, currently under way in multiple facilities throughout the United States, including the University of California, California Stem Cell, Inc., and John Hopkins. Facilities in the Ukraine, Western Europe, Asia, and Latin America are also conducting clinical trials, therapies and treatments utilizing stem cells in the treatment of spinal muscular atrophy. To date, spinal muscular atrophy and Lou Gehrig’s disease, most commonly known as ALS, or amyotrophic lateral sclerosis, have attracted attention by companies around the world as having the greatest potential in motor neuron disease processes that may benefit from targeted stem cell therapies. Clinical trials throughout the United States are
engaged in Phase I and II clinical testing in the use of autologous stem cell transplants. Autologous stem cell transplants utilize a patient’s own bone marrow as a source of adult stem cells, while other studies are utilizing fetal spinal cord tissues or embryonic stem cells. To date, researchers have seen positive benefits of utilizing motor neuron cell based transplants and implantation therapies for the treatment of both SMA and ALS. Stem cell therapy to treat SMA focuses on completely replacing motor neurons that have been damaged or destroyed due to the disease process. Not only will such treatments slow down the disease progression, but may also be used to treat a variety of disorders including spinal cord injuries or other neuromuscular damage or disease processes that interrupts the flow of information signals controlling nerve and muscular movement. Stem cell treatments and technologies offer hope in the future for enhancing quality of life, restoring mobility and muscular function as well as range of motion and stability for
individuals currently diagnosed with SMA.
Stem Cell Treatments Aid Digestive Issues Details
Overview
Digestive issues, most specifically ulcerative colitis and Crohn’s disease, cause more than inconvenience to those diagnosed with such intestinal difficulties. Ulcerative colitis is a form of inflammatory bowel disease, more commonly known as IBD. This condition affects the large portion of the intestine called the colon, and the rectal area. Ulcerative colitis causes sores and inflammation in the lining of the colon and rectum which often bleed. The condition causes the urge to evacuate frequently, and often causes diarrhea. Crohn’s disease is also a form of irritable bowel syndrome, except that Crohn’s disease causes inflammation deeper within the intestinal walls and may also involve other digestive organs, including the small intestine, stomach, esophagus and mouth. Both ulcerative colitis and Crohn’s disease severely limit the ability of some individuals to enjoy normal daily activities. These conditions also cause pain, discomfort and often lead to a sense of isolation and depression in patients diagnosed with these processes.
Common Treatments for Ulcerative colitis and Crohn’s diseaseThe most common treatments utilized for individuals diagnosed with ulcerative colitis or Crohn’s disease are drug therapies that include:Aminosalicylates – help control inflammation that may lead to side effects such as diarrhea, nausea and vomiting. Corticosteroids – hydrocortisone and prednisone commonly prescribed to help reduce inflammation but cause a variety of side effects. Not recommended for long-term
use. Immunomodulator – help to reduce inflammation, but are slow acting and may take up to six months to show benefits. For some, hospitalization or surgery is recommended, requiring many to have their large intestine or portions of their colons removed because of rupture, massive bleeding, or increased cancer risk. In such cases, some patients may retain normal evacuation function, while others must be fitted with colostomy bags, or pouches located on the outside
of the body to collect feces.

Stem Cell Treatments for Ulcerative colitis and Crohn’s disease

Stem cell research facilities and treatment centers have utilized transplantation of fetal stem cells to help treat acute and chronic forms of non inflammatory bowel diseases in those diagnosed with non-specific ulcerative colitis or Crohn’s disease. The efficacy of such treatments is designed to reduce symptoms in patients diagnosed with some form of inflammatory bowel disease including:

Abdominal pain

Daily stool frequency

Stool consistency

Stem cell treatments utilizing the transplantation of fetal stem cells focus on restoring the red blood cell count in hemoglobin levels and competency of the immune system, helping patients maintain longer periods of remission between flare ups. According to research performed by EmCell, a stem cell research facility in the Ukraine, remission in patients with non-specific ulcerative colitis averaged about 13 months, while patients diagnosed with Crohn’s disease experienced remission for between two to three years. Human genome research conducted around the world, including at Cedars-Sinai Medical Center, has focused on identifying genes linked to ulcerative colitis, offering potential stem cell treatments and therapies to treat the disease process. Such stem cell processes involving “rebooting” a patient’s immune system, which is the focus of stem cell research at Nottingham University in Britain, offering increased potential for autologous stem cell transplantation. Clinical trials are underway throughout the globe in utilizing autologous, fetal stem cells, and umbilical stem cell transplantation to treat these digestive issues. Regenerating new, healthy cells into the body is the main focus of stem cell transplantation procedures, and offers hopes to millions around the globe suffering from digestive tract issues or inflammatory bowel symptoms.

How Much do Stem Cell Treatments Cost?

Stem cell treatments have not yet been approved in the U.S. However, costs in other countries depend on the type of stem cell therapy utilized and number of stem cell transplantation or injection sessions. Prices in China prices are generally about $40,000 and placenta stem cell treatments in India and Mexico range about $25,000. Fetal stem cell therapies available in Central Europe are comparable to those in Mexico.

Choosing a Doctor for Stem Cell Therapy Treatments

Check references and resources to determine whether physicians or specialists are trained, experienced and accredited with placenta stem cell therapy treatments with his or
her country of origin and that facilities provide state-of the art technology and equipment and have a well maintained, trained and educated staff.

Stem Cell Treatments for AIDS and HIV Details
Understanding the Difference between Aids and HIVSince its discovery, medical researchers and scientists have searched for an effective method of treating AIDS (Acquired Immuno Deficiency Syndrome) and HIV (Human Immunodeficiency Virus). Being diagnosed as HIV positive does not mean that an individual has AIDS. A person diagnosed with AIDS is considered in the final stages of HIV infection, which severely damages the body’s immune system, placing them at extreme risk of all types of infections.
There are multiple stages of HIV, which range from acute infection to clinical latency, also known as the asymptomatic HIV infection period. At this stage, individuals may not experience signs or symptoms. This stage may last up to eight years or more, depending on the individual. At this stage, it is important for individuals to maintain healthy CD4 cell counts. Near the latter part of the clinical latency stage, the CD4 cell count declines, leaving the individual open to more symptoms and infections as the HIV virus levels in the body increase. AIDS is diagnosed when the CD4 cell count falls below 200 cells per cubic milliliters of blood, according to the AIDS Organization. At this stage, the body’s immune system is severely compromised and without treatment, individuals typically receive a three years life expectancy prognosis. However, individuals exposed to what are known as opportunistic infections may be diagnosed with a one year life expectancy.

Treating AIDS and HIV with Stem Cell Therapy

The focus of most HIV treatments is to get the virus under control, improve patients’ immune system function and overall health and wellness. Today, advancements in stem cell
technologies are improving control of viral and opportunistic infections, as well as treating the decreased immune system function through fetal or embryonic stem cell treatments.

Many countries around the world are offering their own patent-protected technologies and treatments for stem cell technologies addressing immunodeficiency syndrome, including the United States. A stem cell research facility in Ukraine has nearly two decades of experience in treating AIDS and HIV with positive results. According to studies performed by the facility, fetal stem cell transplants help restore and support the immune system function and slow the progression of infections and side effects of the disease process. Such treatments help prevent patients from slipping into the last stage of HIV known as AIDS.

In some cases, treatments can last 1 to 2 years, though patients may be required to repeat treatment courses for longer periods of time, depending on stage, overall physical condition, age, and prognosis. According to studies following nearly 40 patients at the research facility in Ukraine, results show a positive elevation of CD4, CD3, and CD8 cells and lymphocytes through fetal stem cell transplantation.

In other areas around the globe, HIV patients have also experienced positive results from stem cell transplants, including a man who underwent a stem cell transplant at the Charity University of Medicine in Berlin, Germany. Two years following the transplant, the individual is not showing any signs of HIV.

In addition, scientists and researchers at the University of California Los Angeles are working on and antiviral treatment utilizing stem cells that may hold the possibility of immunizing people against the virus.

Over 8,000 people die of AIDS, and 14,000 new infections occur on a daily basis, states the University of California San Francisco AIDS Research Institute. Finding ways to prevent the viral infection, reducing symptoms, and preventing people from slipping into the AIDS stage of the disease are at the top of the list of many stem cell research facilities around the globe, offering hope for improved quality of life and life expectancy in the future.

Stem Cell Treatments for Diabetes Details
Stem cell therapy and technologies are advancing day by day. Treatment of common conditions such as diabetes, hypertension, arthritis and others as the focus of many world renowned stem cell researchers and development facilities around the globe.One of the most popular stem cell treatments, though not without controversy, is the use of embryonic or fetal stem cells for the development of potential treatments and cures for common diseases. However, contrary to popular opinion, embryonic stem cells are not taken from fetuses, but are often utilized with permission by women who have donated their eggs for infertility treatments, and no longer require use of them following a successful conception.

Stem cell researchers continue to be amazed at the use of stem cell therapies to regenerate damage organs and tissues. Hereditary conditions, cancers, blood diseases and conditions such as diabetes mellitus are among the many conditions where stem cell research and development shows positive and effective gains.

Stem cell transplants and treatments for individuals diagnosed with Type 2 diabetes have shown positive results, including lowered blood sugar levels, and in some cases, complete reversal of the diabetic process.

Stem cell research facilities in the Ukraine, Britain, Germany, the United States, and Asia are leading the way in developing consistent treatments and technologies in stem cell therapy and stem cell transplantation to reduce and eradicate the disease process in growing numbers of individuals diagnosed with diabetes mellitus as well as those diagnosed with Type 1 diabetes, known as Juvenile Diabetes.

Backed by the support of the American Diabetes Association and other global diabetics organizations, researchers hoping for cures and better treatments for diabetes understand that embryonic stem cell research offers the best hope for cure and treatment of diabetes, promoting insulin producing cells that will eradicate the need for injections and reduce symptoms of diabetes in the elderly.

Stem Cell Research and Diabetes

Research facilities throughout the globe have spent decades searching for cures to a variety of diseases that affect millions of people. Human embryonic stem cells, also known as ESCs, were first identified and isolated in the late 1990s. Embryonic stem cells have the unique ability to differentiate or morph into any type of cell found in the human body and can remain in a non- specialized form for long periods of time before they are encouraged to morph or develop into specialized cells in a variety of human organ systems.

The Diabetes Research Institute, as well as many other research facilities in the Ukraine, Western Europe, Russia, South America, the United States and Asia have focused on developing cell replacement therapies that restore normal insulin function in those diagnosed with various forms of diabetes. Creating a dependable and unlimited supply of insulin producing cells through cell replacement therapies are currently undergoing clinical trials as well as procedures throughout the globe.

The focus of such technology development is to understand how to promote embryonic stem cells to transform into insulin producing beta cells. This process requires the activation of a variety of genes necessary for the development of insulin producing cells including, according to the Diabetes Research Organization, Nuerogenin 3, Pdx1 and Pax4, Nkx6.1 and Isl-1 genes.

Coaxing for a Cure

Understanding the basics of stem cell research and the staggering potential of embryonic stem cell research and development for potential cures of dozens of disease processes may help take some of the fear and confusion regarding such technology. The future of medical treatments for diabetes may very well lie in stem cell research, technology and stem cell transplantation, offering hope of cure, remission, and optimal health for millions around the world.

Stem Cell Treatments For Rheumatoid Arthritis Details
What is Rheumatoid Arthritis?Rheumatoid arthritis (often known as RA) is a debilitating and painful arthritic bone joint condition that severely limits mobility, range of motion, and quality of life. A painful condition, no cure is yet known for the disease process, although scientists and researchers have long been studying the effects of stem cell transplantation as a potential treatment.

Stem cell therapies focusing on relieving and reducing symptoms of those diagnosed with rheumatoid arthritis are under careful scrutiny by scientists and researchers around the globe.

Stem Cell Treatment for RA

In many facilities around the globe, stem cell treatment of rheumatoid arthritis has shown positive results on individuals who have failed to respond to standard treatments, including anti- inflammatory drug therapy.

Stem cell transplantation therapies performed by a leading stem cell research facility in the Ukraine has shown positive prognosis in mobility, pain, and increase in functional capacity following fetal or embryonic stem cell transplants. Nearly 80 patients followed in their study showed optimal function and relief of symptoms during remission periods following transplantation lasted between six months to three years.

Studies engaged throughout the world, including Central Europe, the United States, and Australia understand that rheumatoid arthritis is an autoimmune disease, and that by replacing damaged cells in the body with healthy ones, remission may be possible. Bone marrow stem cell transplantation is one of the most common methods of treatment, also called autologous hematopoietic stem cell transplantation, and has shown promising results.

Scientists and researchers are also studying adult stem cell transplantation, and studies and Phase I clinical trials have been conducted at the Northwestern University, Feinberg School of Medicine in Chicago, Illinois, in the United States.

While stem cell therapies are not yet approved in the United States, progress in a wide range of studies and clinical trials offer hope for patients suffering from rheumatoid arthritis in the near future. Countries such as Japan, Germany, France, Britain and the Ukraine are also studying and perfecting stem cell technologies that help to reduce symptoms and improve quality of life, range of motion, and mobility in rheumatoid arthritis patients.

According to research and observation of patients engaged in fetal stem cell transplant studies performed at the National Medical University of Ukraine results with patient clinical trials within the test group experiencing fewer periods of inflammation, decreased pain, decrease in fatigue, restricted disease activity, increased mobility and function as well as improved quality of life. According to data released by the facility, most individuals diagnosed with rheumatoid arthritis clinical manifestations displayed a maximum decrease in symptoms 60 days after the stem cell transplantation, and clinical remission was successful in 85% of those cases.

Specifically studied were indices of inflammatory process activity, including:

Hyperthermia

Morning stiffness

Synovitis

Erythrocyte sedimentation

Alfa-2- globulin percentage

C- reactive proteins

Study results following treatment showed a marked decrease of all the above, most notably at the three months to 12 months post-treatment period.

Such positive and promising results in stem cell therapy also further research in blood and bone marrow stem cell transplants to treat autoimmune diseases and conditions such as rheumatoid arthritis, and will continue to offer patients diagnosed with the disease relief of pain, increased mobility, and improved quality of life as research technologies and treatments continue to improve.

Umbilical Cord Stem Cell Therapy Details

Brief Overview

When parents have children, they don’t always think of what might happen in the future. Illness and medical conditions that might occur as the child grows older are now being thought of when parents decide to collect and store their newborn’s umbilical cord blood in a cord bank. During the 1970s, doctors discovered that the blood found within the umbilical cord could supply blood-forming stem cells, and they began to collect and store them in stem cell banks. These special stem cells are capable of turning into three types of mature blood cells that are found in all humans; red and white blood cells, and platelets.

Children who suffer from cancer or other blood diseases must undergo chemotherapy or radiation to treat their condition, but these treatments also harm healthy cells within the body, including the cells in the bone marrow, where red blood cells are formed. For children who need a bone marrow transplant, which can be complicated since a matched donor must be willing to donate bone marrow. Instead, or in combination to a bone marrow transplant, previously stored and healthy umbilical cord blood cells are transplanted into the child, and go on to create new, healthy blood cells which in turn enhance the child’s blood production and immune system.

Umbilical Cord Stem Cell Procurement Procedure

Umbilical cord blood can be collected after either a cesarean or traditional birth. To collect the blood, parents must supply a cord blood kit which they can get from the cord blood bank where they will be storing the cells. In the event of a traditional birth, the umbilical cord is clamped from both ends and cut. An experienced nurse or obstetrician is often able to collect cord blood even before the placenta is delivered. To gather the cord blood, a small tube is inserted into the umbilical vein and collected, and then additional needles are placed within the delivered placenta to gather more valuable blood and cells.

During a cesarean birth, the priority first lies with the mother and her surgical needs. Once the baby has been delivered and the mother is taken care of, the obstetrician can then collect the cord blood. During this type of birth however, less cord blood is available for collection. Once the blood is collected from either type of birth, the cord blood is then placed within syringes or bags and taken to the blood bank. At the blood bank, stem cells are separated from the blood and then cryogenically frozen. In the event they are needed, they are thawed and used. In autologous procedures, an individual will use their own blood cells during a stem cell transplant, while an allogenic procedure allows stem cells from a different individual to be used as long as they are a close match.

Benefits of Umbilical Cord Stem Cell Treatments

The benefit of using umbilical cord stem cells is vital when a child is faced with a medical illness or diseases. Since the placenta and umbilical cord have traditional been discarded, finding these cells increase the chances of survival when an individual is faced with cancers, blood diseases or other ailments. Being frozen cryogenically also means they are available for use at any time, which is very important when faced with cancer or other serious medical condition. Millions of parents have frozen and store their baby’s umbilical cord blood these days, and their numbers are growing. Stem cell research and development is entering an exciting era, and it is hoped that someday soon, multiple
treatments for formerly incurable illnesses and disease processes will be discovered, making storage of umbilical cord blood stem cells invaluable.
Cost of Umbilical Cord Blood Transplants

Many stem cell therapies are not yet approved by the FDA (Federal Drug Administration) in the United States, though the first stem cell transplant utilizing embryonic stem cell transplant tissues was approved in early 2009. Costs for such therapies and transplants are expected to be astronomical for most consumers. However, umbilical cord blood banking is approved. In India, stem cell transplantation costs approximately $18,000 while China offers treatments that may run as high as $30,000 which includes travel expenses and all0inclusive medical attention and care. In the United States, it costs approximately $2,000 to store umbilical cord blood in a cord blood bank.

Choosing a Doctor for Stem Cell Therapy

It is important to find a doctor, obstetrician and delivery team staff experienced in collecting stem cells during the birth of a newborn. Once the stem cells are collected, entrusting them to a reputable blood bank will ensure that they will be there in the event of a medical emergency or illness. Make sure cord blood banks are well equipped and technologically advanced enough to withstand electrical shortages, natural disasters and earthquake damage. Ask how long cord blood may be safely frozen and still provide viable usage.

Stem Cell Therapy for Cartilage Defects

Young and active patients with localized cartilage defects of knee, ankle stand to benefit by a curative operation. A future need for Joint replacement can be avoided. Conditions that are treatable are post traumatic defects, Osteo-chondritis dissecans.

Centre for Knee Surgery

Our center specializes in Knee Replacement, Reconstruction, and Knee Arthroscopy Procedures. This includes:

Gender specific, minimally invasive, ligament sparing, High flexion, Oxford unicondylar knee

High tibial osteotomy, Tibial tubercle osteotomy

Arthroscopic ACL reconstruction, microfracture, menisectomy, patellar stabilization

We have performed total and partial knee joint replacements for Indian & international patients. In comparison to the US you will get up to 90% savings on a knee joint replacement at our center.

Formalities-Overseas patients traveling to Iran will need a visa which is issued by the Iran embassy or High commission in your country. A tourist or medical visa is easy to obtain for which a letter from your doctor may be needed. Just ask and we shall e mail or FAX one to you at the earliest.

Arrival
We give international patients special consideration. Free airport pickup & drop facility is provided. A dedicated concierge (for a small fee) will arrange airport reception, hotel and hospital transfers, local and regional sight seeing and currency exchange. After your arrival, you will be taken either to the hospital or a hotel according to your plan. On arrival in the hospital, you will be admitted under the consultant you have chosen. A customer service representative in the hospital will coordinate all your doctors appointments & travel requirements.
Hospital facilities & expertise at your service

The hospital has the latest diagnostic facilities permitting a rapid diagnosis. There is no waiting time for surgery after your arrival in India.

World class facilities

The most cost conscious overseas patient will find excellent value for money. A choice of rooms is available. Each air- conditioned private room has a wash area, LCD television, room service, laundry, attendant’s couch & bed. You can see a video of the hospital here.

What Is Viral Hepatitis?

Viral hepatitis is a common contagious disease affecting primarily the liver. Although generally a mild condition, hepatitis C is much more likely than hepatitis B to lead to chronic liver disease. People infected with HCV can become chronic carriers of the virus, although they may have no symptoms. This viral attack manifests with different symptoms, varying in intensity as the infection develops. Symptoms of acute hepatitis C infection include:

decreased appetite

fatigue

abdominal pain

jaundice

itching

flu-like symptoms

Medical and dental personnel, firefighters, paramedics, emergency medical technicians, law enforcement officers), and military combat personnel can be exposed to HCV through accidental exposure to blood through accidental needle pricks or blood spatter to the eyes or open wounds.

Stem cell therapy for Anti-aging

Our Integrative Medical Center has helped many sufferers of degenerative diseases around the world with ground breaking medical treatments, services, and procedures. We want you to regain your lost health and vitality.

Placenta / Stem Cell Therapy

According to our experience, we have found that this therapy is very effective for the following conditions:

General Indications:

Chronic fatigue

Stress & anxiety

Insomnia; memory problems

Prior or after a big surgery, chemotherapy or radiation therapy

People that want to keep their body and mind in top condition.

To improve the quality of life of patients with cancer.

Prevention and treatment of Geriatric conditions like senile dementia, Parkinson’s and Alzheimer’s disease.

Degenerative diseases like Osteo-arthritis of knees, hips and back areas.

Other ailments including Retinitis Pigmentosa, Cerebral Palsy or Epilepsy.

Stem Cell Treatment of Multiple Sclerosis

Multiple sclerosis is an insidious auto-immune disease process that destroys the myelin sheaths, which surround axons of the brain and spinal cord. Axons are the main “freeway” of nerve signals that control muscle function, movement, and cognitive abilities. Multiple sclerosis is also known as MS, a condition that literally causes the body’s immune system to attack and destroy its own myelin sheaths, which prevents axons from receiving and sending out signals.

Multiple sclerosis can either be a relapsing form of the disease or progressive form of the disease. In the relapsing form of MS, symptoms may peak and ebb, such as waves in an ocean tide, with long periods of inactivity in between episodes. The progressive form of the disease causes a general increase of symptoms and neurological problems as the disease advances.

Multiple Sclerosis has a wide variety of serious and disabling symptoms such as:

Fatigue

Stiffness and Spasticity

Brain fog

Pain

Excessive daytime sleepiness

Mood swings

Depression

Anxiety

Bladder and bowel problems

Extremely inappropriate emotional expression

Symptoms of MS vary from person to person.

Relapsing-Remitting MS:

People show symptoms of the disease, but then seem to recover. After a period of time, the symptoms appear again. The cycle of symptoms-to-recovery continues over time. This is the most common type of MS.

Primary Progressive MS:

People show gradual worsening of symptoms without recovery.

Secondary Progressive MS:

People first show periods of recovery, but later enter a stage of gradual worsening of symptoms without recovery.

Stem Cell Treatment of Parkinsons Disease

Do you notice tremors in your fingers, hands or legs when you’re resting? Have you noticed that your muscles are more stiff or rigid than usual? Individuals diagnosed with Parkinson’s disease often notice mild to severe changes in the way they walk or how they feel. Alternative therapies to treat postural instability, muscle stiffness, tremors and oppression are available. Dr. Gonzalez of Integra Medical center has treated chronic disease conditions for over a decade with stem cell therapies.

Parkinson’s Disease

Parkinson’s disease is a neurological condition resulting from damage and destruction of brain cells in the basal ganglia, the area of the brain responsible for muscle tone, optimal muscle activity and posture. Cells within the basil ganglia produce a chemical messenger called dopamine, a major brain transmitter. Without that transmitter, movement, speech, and physical coordination declines. Providing Options for Parkinson’s Patients

Reduce tremors that interrupt daily living activities such as writing, walking and driving. Stem cell research and clinical studies have shown benefits in restoring function in individuals diagnosed with Parkinson’s disease. Stem cell therapies, clinical trials and treatments offer:

Reduced tremors

Restoration of fine motor movement

Improved gait and stability

Improved cognitive function

Slowed disease progression

Nearly 40% of individuals diagnosed with Parkinson’s disease try alternative therapies, including stem cell therapies and treatments. When traditional medications don’t work, stem cell therapies may provide the relief you’re looking for.

If you’ve been diagnosed with Stage I to Stage VI of Parkinson’s disease, there is hope in reducing symptoms, slowing the progression of the disease process to enhance and increase quality of life, and increase range of motion and mobility. Individuals seeking alternative methods for alleviating and slowing the symptoms of Parkinson’s disease may find hope and relief through stem cell technologies, and one experienced with treating Parkinson’s disease with stem cell implantation techniques.

Retinitis is a medical term for certain health conditions that affect the eyes. Types of retinitis:

Toxoplasmic Retinitis

This type of retinitis can be inherited or acquired. It is caused by a microorganism. If it was congenital, meaning it was inherited, it was passed to the affected child through the mother’s placenta. Also, a similar kind of retinitis is caused by a blood-borne infection that settles in the eye of the affected person.

Retinitis Pigmentosa

This type of retinitis is an inherited disorder in which a substance called phytanic acid reaches excessive levels thereby causing extensive damage to the retina.
Exudative Retinitis

In this type of retinitis the retina may detach from the eyeball’s internal surface. Cytomegalovirus Retinitis

Known as CMV, this is the most common severe infection affecting the eye in patients with AIDS. If left untreated, CMV can destroy a person’s eyesight in as little as two to six months. Cytomegalovirus is a herpes virus that usually does not cause symptoms in people with a normal functioning immune system. However, CMV can cause serious infections in those who have AIDS or an organ transplant, or those who are treated with chemotherapy.

Placenta Stem Cell Therapy

Placenta stem cell therapy is a type of adult stem cell therapy that utilizes the placenta, or afterbirth of a woman who has undergone the child birthing process. Specializing in placenta stem cell therapy and degenerative diseases, we are in the field of stem cell treatments for chronic fatigue, insomnia, stress and anxiety, autoimmune diseases like multiple sclerosis, lupus and diabetes, kidney disorders, muscular dystrophy, as well as chronic infections and fatigue, tuberculosis, AIDS, Hepatitis C, and a particular treatment just for anti-aging. Placenta stem cell therapy (PST) has been researched for over two decades, but only recently have researchers and scientists understood the impact that placenta stem cell therapy and treatment has on a multitude of auto-immune and chronic illness conditions and symptoms. Placenta stem cell therapy does not harm a fetus, infant or mother. Placenta stem cells are gathered from the placenta following a rigorous methodology and protocol according to international normative. Placenta stem cell harvesting is considered an ethical procedure that takes advantage of multipotent stem cells found in the placental afterbirth.

POWER BY ROHANCELL 2017